GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sirona Dental Systems Inc (NAS:SIRO) » Definitions » EBITDA

Sirona Dental Systems (Sirona Dental Systems) EBITDA : $320 Mil (TTM As of Dec. 2015)


View and export this data going back to . Start your Free Trial

What is Sirona Dental Systems EBITDA?

Sirona Dental Systems's EBITDA for the three months ended in Dec. 2015 was $83 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2015 was $320 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Sirona Dental Systems's EBITDA per Share for the three months ended in Dec. 2015 was $1.46. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2015 was $5.66.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Sirona Dental Systems EBITDA Historical Data

The historical data trend for Sirona Dental Systems's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Dental Systems EBITDA Chart

Sirona Dental Systems Annual Data
Trend Mar06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 244.59 260.60 277.10 310.60 317.60

Sirona Dental Systems Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.70 67.20 97.30 72.40 82.60

Competitive Comparison of Sirona Dental Systems's EBITDA

For the Medical Instruments & Supplies subindustry, Sirona Dental Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Dental Systems's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sirona Dental Systems's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sirona Dental Systems's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sirona Dental Systems's EBITDA for the fiscal year that ended in Sep. 2015 is calculated as

Sirona Dental Systems's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Sep. 2015, Sirona Dental Systems's EBITDA was $318 Mil.

Sirona Dental Systems's EBITDA for the quarter that ended in Dec. 2015 is calculated as

Sirona Dental Systems's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2015, Sirona Dental Systems's EBITDA was $83 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $320 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Sirona Dental Systems  (NAS:SIRO) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Sirona Dental Systems EBITDA Related Terms

Thank you for viewing the detailed overview of Sirona Dental Systems's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Dental Systems (Sirona Dental Systems) Business Description

Traded in Other Exchanges
N/A
Address
Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, dental equipment, and is engaged in developing, manufacturing and marketing solutions for dentists around the world. The Company provides products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include international companies as well as smaller companies that compete regionally or on a narrower product line. The Company is subject to government regulations applicable to all businesses
Executives
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Arthur D Kowaloff director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Walter Petersohn officer: Executive VP of Sales C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
David Beecken director DENTSPLY SIRONA INC, 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Thomas Jetter director DENTSPLY SIRONA INC, 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ulrich Michel officer: CFO and Exec. Vice President CHAUSEE DE WAVRE, 1789, CARE OF WABCO HOLDINGS INC, BRUSSELS C9 1160
Rainer Berthan officer: Executive VP C/O SIRONA DENTAL SYSTEMS, INC., FABRIKSTRASSE, BENSHEIM 2M 31D-64625
Jeffrey Slovin director, officer: Chief Executive Officer DENTSPLY SIRONA INC., 30-30 47TH AVE, SUITE 500, LONG ISLAND CITY NY 11101
Jonathan I Friedman officer: General Counsel and Secretary DENTSPLY SIRONA INC., 30-30 47TH AVENUE, SUITE 500, LONG ISLAND CITY NY 11101
Timothy P Sullivan director THREE FIRST NATIONAL PLZ, SUITE 3800, CHICAGO IL 60602
Simone Blank director, officer: Executive VP and CFO C/O SIRONA, WASSERFELDSTRASSE 30 A-5020, SALZBURG C4 5020
Nicholas W Alexos director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Stephen Rosenberg 10 percent owner 1004 FARNAM STREET, SUITE 400, OMAHA NE 68102
Uri Landesman director 230 PARK AVENUE, NEW YORK NY 10169

Sirona Dental Systems (Sirona Dental Systems) Headlines